Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...

IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

Psoriasis experts say the PASI is not practical ... Some patients will say during their first visit that they don't want a pill or don't want an injection, so I try to document all of that and ...

Dry skin, itching, and fiery eczema can be caused by allergens, stress, or an overactive immune response.Steroid creams ...

Medicare coverage for psoriasis drugs depends on the type of Medicare plan you have and the drug your doctor prescribes. But if your doctor considers a drug medically necessary, Medicare may cover it.

At one point BMS was pitching its TYK2 drug as offering efficacy in line with injectable biologic drugs for psoriasis, but with the convenience of oral dosing, although the final readouts from its ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria.

also prescribes adalimumab for many of his patients with skin psoriasis and psoriatic arthritis. "I still think it works better for arthritis than the IL-17 and IL-23 drugs," he said. Every ...